The NEPHSTROM project held an online plenary meeting on Friday, 9 March 2021. Representatives from each of the project partners gathered to discuss the recently granted six-month no-cost extension and to plan for the remainder of the project.
The meeting provided an opportunity to mark the inclusion of the final patient at the Bergamo trial site. Participants are still being enrolled in the trial sites at Galway and Birmingham. The Clinical Research Facility in Galway reports that enrolment for the mid-dose cohort receiving 160 million cells has commenced at Galway University Hospital with 2 people enrolled so far. For specifics of the NEPHSTROM clinical trial, see https://nephstrom.eu/the-project/the-clinical-trial/.
The NEPHSTROM partners look forward to bringing the trial and the project to a successful conclusion.